HitGen
VC Fund
Chengdu, China
HitGen is a VC fund in Chengdu focused on Genetics and Oncology. HitGen is provides biological reagents and services to support drug discovery research.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries HitGen invests in
Stages HitGen invests in
Countries HitGen invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Genetics 1 (100%)
- Oncology 1 (100%)
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Barry A. Morgan
Chief Scientific Officer
|
Chief Scientific Officer | Total investments: 0 | Find email | |
Jin Li
Founder, Chairman & CEO
|
Founder, Chairman & CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Connexus Therapeutics
|
Connexus Therapeutics is a private, venture-backed biotechnology startup. | $5M / Series A / Sep 17, 2026 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does HitGen invest in?
HitGen invests primarily in Genetics, Oncology and Life Science startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact HitGen?
Public channels for HitGen include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HitGen?
The team at HitGen includes Barry A. Morgan (Chief Scientific Officer) and Jin Li (Founder, Chairman & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
